BHWM
PTCT icon

Bay Harbor Wealth Management’s PTC Therapeutics PTCT Stock Holding History

Bay Harbor Wealth Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06K Buy
13
+3
+30% +$217 ﹤0.01% 847
2026
Q1 		$681 Buy
10
+3
+43% +$212 ﹤0.01% 900
2025
Q4 		$531 Buy
7
+2
+40% +$145 ﹤0.01% 835
2025
Q3 		$306 Buy
5
+3
+150% +$156 ﹤0.01% 905
2025
Q2 		$97 Buy
2
+1
+100% +$47 ﹤0.01% 1109
2025
Q1 		$50 Buy
+1
New +$50 ﹤0.01% 1028

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Bay Harbor Wealth Management's PTCT Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its PTC Therapeutics (PTCT) stake by 30% in Q2 2026, buying an estimated $217 and bringing the position to 13 shares worth $1.06K. The position accounts for ﹤0.01% of the portfolio, ranked #847.

Bay Harbor Wealth Management first reported a position in PTCT in Q1 2025 and has held it in 6 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Bay Harbor Wealth Management held 13 shares of PTC Therapeutics worth $1.06K as of Q2 2026.
  • Bay Harbor Wealth Management bought 3 PTC Therapeutics shares in Q2 2026, an estimated $217.
  • PTC Therapeutics made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #847 holding.
  • Bay Harbor Wealth Management first reported a position in PTC Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.